Drug
Men1309
Men1309: highest development phase Phase 1, developed by Menarini. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Menarini
Trials
| Drug | Phase | Indication |
|---|---|---|
| MEN1309 NCT03403725 | Phase 1 | Metastatic Solid Tumors |
Latest
No recent events.
Follow Men1309 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.